Related Experiment Video
Updated: Jul 13, 2026

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Published on: April 11, 2019
Divalproex sodium in severe anaemia: a case report
1Deaf Mental Health Services, Specialities Directorate, Birmingham and Solihull Mental Health NHS Trust Birmingham, UK. maneesh_psych@yahoo.com
Divalproex sodium may cause severe side effects in patients with severe anemia. This case study highlights the risks of prescribing this psychotropic drug to an anemic patient, leading to discontinuation due to adverse effects.
Area of Science:
- Psychiatry and Hematology
- Clinical Pharmacology
Background:
- Limited data exists on psychotropic medication use in patients with severe anemia.
- Anemia can affect drug metabolism and increase sensitivity to side effects.
Purpose of the Study:
- To report a case of psychotropic drug administration in a patient with severe anemia.
- To highlight potential adverse effects and considerations for prescribing in this population.
Main Methods:
- A case presentation of a 36-year-old male with severe anemia.
- The patient was prescribed divalproex sodium 250 mg daily for mood swings.
- Adverse events and treatment outcome were monitored.
Main Results:
- The patient experienced unbearable side effects from divalproex sodium.
- Medication was discontinued after nine days due to adverse reactions.
- Severe anemia may be a risk factor for divalproex sodium intolerance.
Conclusions:
- Divalproex sodium can lead to severe side effects in patients with severe anemia.
- Clinicians should exercise caution when prescribing psychotropic drugs to anemic patients.
- Further research is needed to understand the interaction between anemia and psychotropic medications.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pharmaceutical Poisoning: Treatment Strategies
Hepatic Encephalopathy